Trials / Completed
CompletedNCT05516225
Safety Study of Human Milk Oligosaccharides in Healthy Adults
Phase 1 Safety Study of Human Milk Oligosaccharide Concentrate PBCLN-003 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Prolacta Bioscience · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
First-in-human phase 1 study conducted in healthy adult male and female volunteers to determine the safety and tolerability of increasing doses of PBCLN-003, which are concentrated human milk oligosaccharides (HMO).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PBCLN-003 | Human Milk Oligosaccharide Concentrate |
Timeline
- Start date
- 2016-09-29
- Primary completion
- 2017-02-13
- Completion
- 2017-02-13
- First posted
- 2022-08-25
- Last updated
- 2022-08-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05516225. Inclusion in this directory is not an endorsement.